These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


235 related items for PubMed ID: 12791736

  • 21. Flu-fighting options: decisions, decisions...
    Rosen DS.
    Health News; 2000 Dec; 6(12):4. PubMed ID: 11142939
    [No Abstract] [Full Text] [Related]

  • 22. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec 17; 48(RR-14):1-9. PubMed ID: 10632443
    [Abstract] [Full Text] [Related]

  • 23. Influenza virus neuraminidase inhibitors.
    Gubareva LV, Kaiser L, Hayden FG.
    Lancet; 2000 Mar 04; 355(9206):827-35. PubMed ID: 10711940
    [Abstract] [Full Text] [Related]

  • 24. Updated treatment for influenza A and B.
    Montalto NJ, Gum KD, Ashley JV.
    Am Fam Physician; 2000 Dec 01; 62(11):2467-76. PubMed ID: 11130232
    [Abstract] [Full Text] [Related]

  • 25. [Pneumonia diagnosis in the practice on the test-bench: how much diagnosis is necessary?].
    Vogel GE.
    Dtsch Med Wochenschr; 2002 Mar 15; 127(11):580; author reply 580.. PubMed ID: 11894183
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Critical review of anti-influenza drugs].
    van Loon FP, Voordouw AC, Simonian S, Koopmans PP.
    Ned Tijdschr Geneeskd; 2000 Jan 22; 144(4):165-7. PubMed ID: 10668542
    [Abstract] [Full Text] [Related]

  • 29. Progress treating, preventing influenza.
    Stephenson J.
    JAMA; 1998 Nov 25; 280(20):1729-30. PubMed ID: 9842933
    [No Abstract] [Full Text] [Related]

  • 30. Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza.
    Dreitlein WB, Maratos J, Brocavich J.
    Clin Ther; 2001 Mar 25; 23(3):327-55. PubMed ID: 11318072
    [Abstract] [Full Text] [Related]

  • 31. The relentless flu drug.
    Environ Health Perspect; 1998 Aug 25; 106(8):A372-3. PubMed ID: 9867459
    [No Abstract] [Full Text] [Related]

  • 32. Position statement: global neuraminidase inhibitor susceptibility network.
    Zambon M, Hayden FG, Global Neuraminidase Inhibitor Susceptibility Network.
    Antiviral Res; 2001 Mar 25; 49(3):147-56. PubMed ID: 11428241
    [No Abstract] [Full Text] [Related]

  • 33. [Drug regulatory agency comments on the editorial about the new influenza drugs].
    Tokola O, Pasanen M.
    Duodecim; 2000 Mar 25; 116(6):626-7. PubMed ID: 11787114
    [No Abstract] [Full Text] [Related]

  • 34. [Anti-virals for influenza virus infection].
    Sugaya N.
    Uirusu; 2005 Jun 25; 55(1):111-4. PubMed ID: 16308537
    [Abstract] [Full Text] [Related]

  • 35. Neuraminidase inhibitors: zanamivir and oseltamivir.
    McNicholl IR, McNicholl JJ.
    Ann Pharmacother; 2001 Jan 25; 35(1):57-70. PubMed ID: 11197587
    [Abstract] [Full Text] [Related]

  • 36. Treating influenza with zanamivir.
    Read RC.
    Lancet; 1998 Dec 12; 352(9144):1872-3. PubMed ID: 9863779
    [No Abstract] [Full Text] [Related]

  • 37. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
    Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG.
    BMJ; 2003 Jun 07; 326(7401):1235. PubMed ID: 12791735
    [Abstract] [Full Text] [Related]

  • 38. Flu drugs. Have I got news for flu.
    Snell J.
    Health Serv J; 2000 Jan 27; 110(5689):suppl 5. PubMed ID: 11184398
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.